SANOFI (SNW.DE) Stock Fundamental Analysis

FRA:SNW • FR0000120578

77.95 EUR
-1.39 (-1.75%)
Last: Feb 13, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

4

Taking everything into account, SNW scores 4 out of 10 in our fundamental rating. SNW was compared to 52 industry peers in the Pharmaceuticals industry. There are concerns on the financial health of SNW while its profitability can be described as average. SNW is not valued too expensively and it also shows a decent growth rate. SNW also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year SNW was profitable.
  • In the past 5 years SNW has always been profitable.
  • Each year in the past 5 years SNW had a positive operating cash flow.
SNW.DE Yearly Net Income VS EBIT VS OCF VS FCFSNW.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • SNW has a Return On Assets of 10.63%. This is in the better half of the industry: SNW outperforms 72.73% of its industry peers.
  • SNW has a Return On Equity (18.84%) which is in line with its industry peers.
  • Looking at the Return On Invested Capital, with a value of 13.35%, SNW is in line with its industry, outperforming 60.00% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for SNW is significantly below the industry average of 14.38%.
  • The last Return On Invested Capital (13.35%) for SNW is above the 3 year average (7.41%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 10.63%
ROE 18.84%
ROIC 13.35%
ROA(3y)4.87%
ROA(5y)5.28%
ROE(3y)8.47%
ROE(5y)9.13%
ROIC(3y)7.41%
ROIC(5y)7.45%
SNW.DE Yearly ROA, ROE, ROICSNW.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • SNW has a Profit Margin of 20.63%. This is in the better half of the industry: SNW outperforms 76.36% of its industry peers.
  • SNW's Profit Margin has declined in the last couple of years.
  • SNW's Operating Margin of 23.61% is in line compared to the rest of the industry. SNW outperforms 52.73% of its industry peers.
  • In the last couple of years the Operating Margin of SNW has grown nicely.
  • SNW has a Gross Margin of 72.29%. This is comparable to the rest of the industry: SNW outperforms 49.09% of its industry peers.
  • In the last couple of years the Gross Margin of SNW has remained more or less at the same level.
Industry RankSector Rank
OM 23.61%
PM (TTM) 20.63%
GM 72.29%
OM growth 3Y-0.84%
OM growth 5Y1.78%
PM growth 3Y-3.21%
PM growth 5Y-12.66%
GM growth 3Y1.06%
GM growth 5Y1.33%
SNW.DE Yearly Profit, Operating, Gross MarginsSNW.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SNW is still creating some value.
  • SNW has less shares outstanding than it did 1 year ago.
  • SNW has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, SNW has a worse debt to assets ratio.
SNW.DE Yearly Shares OutstandingSNW.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
SNW.DE Yearly Total Debt VS Total AssetsSNW.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • A Debt/Equity ratio of 0.18 indicates that SNW is not too dependend on debt financing.
  • SNW has a better Debt to Equity ratio (0.18) than 76.36% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC1.68
WACC7.96%
SNW.DE Yearly LT Debt VS Equity VS FCFSNW.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.3 Liquidity

  • A Current Ratio of 1.06 indicates that SNW should not have too much problems paying its short term obligations.
  • SNW's Current ratio of 1.06 is on the low side compared to the rest of the industry. SNW is outperformed by 78.18% of its industry peers.
  • SNW has a Quick Ratio of 1.06. This is a bad value and indicates that SNW is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.30, SNW is not doing good in the industry: 92.73% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.3
SNW.DE Yearly Current Assets VS Current LiabilitesSNW.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • SNW shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.82%.
  • The Earnings Per Share has been growing slightly by 5.58% on average over the past years.
  • The Revenue has been growing slightly by 5.49% in the past year.
  • Measured over the past years, SNW shows a small growth in Revenue. The Revenue has been growing by 4.57% on average per year.
EPS 1Y (TTM)1.82%
EPS 3Y-1.77%
EPS 5Y5.58%
EPS Q2Q%16.79%
Revenue 1Y (TTM)5.49%
Revenue growth 3Y0.97%
Revenue growth 5Y4.57%
Sales Q2Q%7%

3.2 Future

  • Based on estimates for the next years, SNW will show a small growth in Earnings Per Share. The EPS will grow by 7.70% on average per year.
  • The Revenue is expected to grow by 4.86% on average over the next years.
EPS Next Y8.1%
EPS Next 2Y6.92%
EPS Next 3Y8.79%
EPS Next 5Y7.7%
Revenue Next Year6.49%
Revenue Next 2Y6.66%
Revenue Next 3Y5.93%
Revenue Next 5Y4.86%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
SNW.DE Yearly Revenue VS EstimatesSNW.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B 50B
SNW.DE Yearly EPS VS EstimatesSNW.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 9.97, the valuation of SNW can be described as very reasonable.
  • SNW's Price/Earnings ratio is rather cheap when compared to the industry. SNW is cheaper than 83.64% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of SNW to the average of the S&P500 Index (26.68), we can say SNW is valued rather cheaply.
  • SNW is valuated reasonably with a Price/Forward Earnings ratio of 9.22.
  • SNW's Price/Forward Earnings ratio is rather cheap when compared to the industry. SNW is cheaper than 94.55% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.06. SNW is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 9.97
Fwd PE 9.22
SNW.DE Price Earnings VS Forward Price EarningsSNW.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SNW.DE Per share dataSNW.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • SNW's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.23
PEG (5Y)1.79
EPS Next 2Y6.92%
EPS Next 3Y8.79%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

8

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 5.21%, SNW is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 1.89, SNW pays a better dividend. On top of this SNW pays more dividend than 89.09% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.84, SNW pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.21%

5.2 History

  • The dividend of SNW has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years6
Div Non Decr Years6
SNW.DE Yearly Dividends per shareSNW.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

  • 34.36% of the earnings are spent on dividend by SNW. This is a low number and sustainable payout ratio.
  • The dividend of SNW is growing, but earnings are growing more, so the dividend growth is sustainable.
DP34.36%
EPS Next 2Y6.92%
EPS Next 3Y8.79%
SNW.DE Yearly Income VS Free CF VS DividendSNW.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B
SNW.DE Dividend Payout.SNW.DE Dividend Payout, showing the Payout Ratio.SNW.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

SANOFI

FRA:SNW (2/13/2026, 7:00:00 PM)

77.95

-1.39 (-1.75%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)01-29
Earnings (Next)04-23
Inst Owners46.74%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap188.27B
Revenue(TTM)46.72B
Net Income(TTM)13.80B
Analysts77.33
Price Target100.48 (28.9%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.21%
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.36%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.79%
Min EPS beat(2)-2.29%
Max EPS beat(2)5.86%
EPS beat(4)2
Avg EPS beat(4)1.85%
Min EPS beat(4)-2.29%
Max EPS beat(4)6.02%
EPS beat(8)5
Avg EPS beat(8)3.19%
EPS beat(12)7
Avg EPS beat(12)2.67%
EPS beat(16)11
Avg EPS beat(16)3.3%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)0
Avg Revenue beat(4)-1.95%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)-0.63%
Revenue beat(8)2
Avg Revenue beat(8)-1%
Revenue beat(12)4
Avg Revenue beat(12)9.01%
Revenue beat(16)8
Avg Revenue beat(16)21.12%
PT rev (1m)-5.63%
PT rev (3m)-5.58%
EPS NQ rev (1m)0.35%
EPS NQ rev (3m)2.34%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.58%
Revenue NQ rev (1m)1%
Revenue NQ rev (3m)1.85%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.64%
Valuation
Industry RankSector Rank
PE 9.97
Fwd PE 9.22
P/S 2.81
P/FCF N/A
P/OCF N/A
P/B 2.57
P/tB 42.83
EV/EBITDA N/A
EPS(TTM)7.82
EY10.03%
EPS(NY)8.45
Fwd EY10.84%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS27.7
BVpS30.33
TBVpS1.82
PEG (NY)1.23
PEG (5Y)1.79
Graham Number73.06
Profitability
Industry RankSector Rank
ROA 10.63%
ROE 18.84%
ROCE 16.17%
ROIC 13.35%
ROICexc 14.69%
ROICexgc 65.49%
OM 23.61%
PM (TTM) 20.63%
GM 72.29%
FCFM N/A
ROA(3y)4.87%
ROA(5y)5.28%
ROE(3y)8.47%
ROE(5y)9.13%
ROIC(3y)7.41%
ROIC(5y)7.45%
ROICexc(3y)8.06%
ROICexc(5y)8.26%
ROICexgc(3y)31.82%
ROICexgc(5y)35.77%
ROCE(3y)8.99%
ROCE(5y)9.04%
ROICexgc growth 3Y-8.07%
ROICexgc growth 5Y1.04%
ROICexc growth 3Y-0.36%
ROICexc growth 5Y3.93%
OM growth 3Y-0.84%
OM growth 5Y1.78%
PM growth 3Y-3.21%
PM growth 5Y-12.66%
GM growth 3Y1.06%
GM growth 5Y1.33%
F-ScoreN/A
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.3
Altman-Z N/A
F-ScoreN/A
WACC7.96%
ROIC/WACC1.68
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)127.25%
Profit Quality(5y)123.49%
High Growth Momentum
Growth
EPS 1Y (TTM)1.82%
EPS 3Y-1.77%
EPS 5Y5.58%
EPS Q2Q%16.79%
EPS Next Y8.1%
EPS Next 2Y6.92%
EPS Next 3Y8.79%
EPS Next 5Y7.7%
Revenue 1Y (TTM)5.49%
Revenue growth 3Y0.97%
Revenue growth 5Y4.57%
Sales Q2Q%7%
Revenue Next Year6.49%
Revenue Next 2Y6.66%
Revenue Next 3Y5.93%
Revenue Next 5Y4.86%
EBIT growth 1Y9.12%
EBIT growth 3Y0.11%
EBIT growth 5Y6.43%
EBIT Next Year28.46%
EBIT Next 3Y13.63%
EBIT Next 5Y7.52%
FCF growth 1Y85.47%
FCF growth 3Y9.46%
FCF growth 5Y15.4%
OCF growth 1Y20.22%
OCF growth 3Y1.22%
OCF growth 5Y8.03%

SANOFI / SNW.DE FAQ

Can you provide the ChartMill fundamental rating for SANOFI?

ChartMill assigns a fundamental rating of 5 / 10 to SNW.DE.


What is the valuation status of SANOFI (SNW.DE) stock?

ChartMill assigns a valuation rating of 5 / 10 to SANOFI (SNW.DE). This can be considered as Fairly Valued.


How profitable is SANOFI (SNW.DE) stock?

SANOFI (SNW.DE) has a profitability rating of 6 / 10.


Can you provide the financial health for SNW stock?

The financial health rating of SANOFI (SNW.DE) is 3 / 10.


What is the earnings growth outlook for SANOFI?

The Earnings per Share (EPS) of SANOFI (SNW.DE) is expected to grow by 8.1% in the next year.